Edward F. Mackey

2019

In 2019, Edward F. Mackey earned a total compensation of $3.2M as Executive Vice President, Operations at Boston Scientific.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$156,573
Non-Equity Incentive Plan$520,282
Option Awards$437,491
Salary$577,398
Stock Awards$1,472,367
Other$34,851
Total$3,198,962

Mackey received $1.5M in stock awards, accounting for 46% of the total pay in 2019.

Mackey also received $156.6K of change in pension value and nonqualified deferred compensation earnings, $520.3K in non-equity incentive plan, $437.5K in option awards, $577.4K in salary and $34.9K in other compensation.

Rankings

In 2019, Edward F. Mackey's compensation ranked 3,814th out of 13,971 executives tracked by ExecPay. In other words, Mackey earned more than 72.7% of executives.

ClassificationRankingPercentile
All
3,814
out of 13,971
73rd
Division
Manufacturing
1,379
out of 5,701
76th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
186
out of 832
78th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
102
out of 535
81st
Industry
Surgical and Medical Instruments and Apparatus
63
out of 350
82nd

Pay ratio

Edward F. Mackey's Pay$3,198,962
Median Employee's Pay$65,630
Pay Ratio

49

to 1

In 2019, the annual total compensation of Edward F. Mackey was $3,198,962.

The annual total compensation of the median employee at Boston Scientific was $65,630.

The ratio of Edward F. Mackey's pay to the pay of median employee was therefore 49 to one.

Source: SEC filing on March 25, 2020.

Mackey's colleagues

We found four more compensation records of executives who worked with Edward F. Mackey at Boston Scientific in 2019.

2019

Michael Mahoney

Boston Scientific

Chief Executive Officer

2019

Daniel Brennan

Boston Scientific

Chief Financial Officer

2019

Joseph Fitzgerald

Boston Scientific

Executive Vice President and President, Rhythm Management

2019

Kevin Ballinger

Boston Scientific

Executive Vice President and President, Interventional Cardiology

News

You may also like